The only way is up – or is it? Pharma & biotech at the end of Q2
In a world awash with information, Evaluate is here to provide clarity with best-in-class data and expert insight.
As we come to the end of a very rocky first half of 2022, where to from here? We share a snapshot of the pharma, biotech and medtech markets to bring you up to speed and help guide you forward.